Lu Chris Xiangyang增持来凯医药-B(02105)约1.68万股 每股作价7.1279港元

智通财经APP获悉，香港联交所最新数据显示，7月7日，Lu Chris Xiangyang增持来凯医药-B(02105)1.6846万股，每股作价7.1279港元，总金额约为12万港元。增持后最新持股数目约为5510.28万股，最新持股比例为12.26%。

补充资料：Shares held by Dr. Lu includes (i) 27,592,316 Shares held beneficially under his name, (ii) 20,000,000 Shares held by Ealex LLC of which Dr. Lu is the settlor, (iii) Share Options granted to Dr. Lu to subscribe for 2,635,520 Shares pursuant to the Pre-IPO Share Option Scheme, and (iv) 4,875,000 Shares underlying the RSUs granted under the 2024 Share Award Scheme.